{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:30:29Z","timestamp":1792621829853,"version":"4.5.0"},"publisher-location":"New York, NY","reference-count":22,"publisher":"Springer New York","isbn-type":[{"value":"9781493990641","type":"print"},{"value":"9781493990658","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9065-8_18","type":"book-chapter","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T08:22:54Z","timestamp":1548922974000},"page":"281-294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Systemic Delivery of Adeno-Associated Viral Vectors in Mice and Dogs"],"prefix":"10.1007","author":[{"given":"Lakmini P.","family":"Wasala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chady H.","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Nora","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"issue":"10097","key":"18_CR1","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","volume":"390","author":"S Russell","year":"2017","unstructured":"Russell S, Bennett J, Wellman JA et al (2017) Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 390(10097):849\u2013860. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(17)31868-8","journal-title":"Lancet"},{"key":"18_CR2","unstructured":"FDA News Release (2017) FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss. \n                    https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm589467.htm\n                    \n                  . Accessed 19 Dec 2017"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.coviro.2016.07.006","volume":"21","author":"D Duan","year":"2016","unstructured":"Duan D (2016) Systemic delivery of adeno-associated viral vectors. Curr Opin Virol 21:16\u201325. \n                    https:\/\/doi.org\/10.1016\/j.coviro.2016.07.006","journal-title":"Curr Opin Virol"},{"issue":"18","key":"18_CR4","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R et al (2017) Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med 377(18):1713\u20131722. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1706198","journal-title":"N Engl J Med"},{"issue":"8","key":"18_CR5","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nm1085","volume":"10","author":"P Gregorevic","year":"2004","unstructured":"Gregorevic P, Blankinship MJ, Allen JM et al (2004) Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 10(8):828\u2013834","journal-title":"Nat Med"},{"issue":"12","key":"18_CR6","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1038\/mt.2008.207","volume":"16","author":"Y Yue","year":"2008","unstructured":"Yue Y, Ghosh A, Long C et al (2008) A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Mol Ther 16(12):1944\u20131952. \n                    https:\/\/doi.org\/10.1038\/mt.2008.207","journal-title":"Mol Ther"},{"issue":"20","key":"18_CR7","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.1093\/hmg\/ddv310","volume":"24","author":"Y Yue","year":"2015","unstructured":"Yue Y, Pan X, Hakim CH et al (2015) Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus. Hum Mol Genet 24(20):5880\u20135890","journal-title":"Hum Mol Genet"},{"issue":"22","key":"18_CR8","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/sj.gt.3303029","volume":"14","author":"B Bostick","year":"2007","unstructured":"Bostick B, Ghosh A, Yue Y et al (2007) Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration. Gene Ther 14(22):1605\u20131609","journal-title":"Gene Ther"},{"issue":"4","key":"18_CR9","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/sj.mt.6300081","volume":"15","author":"A Ghosh","year":"2007","unstructured":"Ghosh A, Yue Y, Long C et al (2007) Efficient whole-body transduction with trans-splicing adeno-associated viral vectors. Mol Ther 15(4):750\u2013755. \n                    https:\/\/doi.org\/10.1038\/sj.mt.6300081","journal-title":"Mol Ther"},{"issue":"8","key":"18_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1089\/hum.2008.058","volume":"19","author":"B Bostick","year":"2008","unstructured":"Bostick B, Yue Y, Lai Y et al (2008) Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice. Hum Gene Ther 19(8):851\u2013856. \n                    https:\/\/doi.org\/10.1089\/hum.2008.058","journal-title":"Hum Gene Ther"},{"issue":"11","key":"18_CR11","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1089\/hum.2009.058","volume":"20","author":"A Ghosh","year":"2009","unstructured":"Ghosh A, Yue Y, Shin J-H et al (2009) Systemic trans-splicing AAV delivery efficiently transduces the heart of adult mdx mouse, a model for Duchenne muscular dystrophy. Hum Gene Ther 20(11):1319\u20131328","journal-title":"Hum Gene Ther"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/978-1-61737-982-6_21","volume":"709","author":"Y Yue","year":"2011","unstructured":"Yue Y, Shin JH, Duan D (2011) Whole body skeletal muscle transduction in neonatal dogs with AAV-9. Methods Mol Biol 709:313\u2013329. \n                    https:\/\/doi.org\/10.1007\/978-1-61737-982-6_21","journal-title":"Methods Mol Biol"},{"issue":"2","key":"18_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.yjmcc.2012.05.002","volume":"53","author":"B Bostick","year":"2012","unstructured":"Bostick B, Shin JH, Yue Y et al (2012) AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy. J Mol Cell Cardiol 53(2):217\u2013222. S0022-2828(12)00179-4 [pii]. \n                    https:\/\/doi.org\/10.1016\/j.yjmcc.2012.05.002","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"18_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1089\/hum.2013.044","volume":"24","author":"X Pan","year":"2013","unstructured":"Pan X, Yue Y, Zhang K et al (2013) Long-term robust myocardial transduction of the dog heart from a peripheral vein by adeno-associated virus serotype-8. Hum Gene Ther 24(6):584\u2013594. \n                    https:\/\/doi.org\/10.1089\/hum.2013.044","journal-title":"Hum Gene Ther"},{"key":"18_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2014.2","volume":"1","author":"CH Hakim","year":"2014","unstructured":"Hakim CH, Yue Y, Shin JH et al (2014) Systemic gene transfer reveals distinctive muscle transduction profile of tyrosine mutant AAV-1, \u22126, and \u22129 in neonatal dogs. Mol Ther Methods Clin Dev 1:14002. \n                    https:\/\/doi.org\/10.1038\/mtm.2014.2","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"18","key":"18_CR16","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/hmg\/ddt224","volume":"22","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Yue Y, Li L et al (2013) Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy. Hum Mol Genet 22(18):3720\u20133729. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddt224","journal-title":"Hum Mol Genet"},{"issue":"4","key":"18_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1089\/hgtb.2014.128","volume":"26","author":"X Pan","year":"2015","unstructured":"Pan X, Yue Y, Zhang K et al (2015) AAV-8 is more efficient than AAV-9 in transducing neonatal dog heart. Hum Gene Ther Methods 26(4):54\u201361","journal-title":"Hum Gene Ther Methods"},{"issue":"Suppl 1","key":"18_CR18","doi-asserted-by":"publisher","first-page":"S198","DOI":"10.1016\/S1525-0016(16)33308-1","volume":"24","author":"CH Hakim","year":"2016","unstructured":"Hakim CH, Pan X, Kodippili K et al (2016) Intravenous delivery of a novel micro-dystrophin vector prevented muscle deterioration in young adult canine Duchenne muscular dystrophy dogs. Mol Ther 24(Suppl 1):S198\u2013S199","journal-title":"Mol Ther"},{"issue":"4","key":"18_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1089\/hum.2017.042","volume":"28","author":"RM Kotin","year":"2017","unstructured":"Kotin RM, Snyder RO (2017) Manufacturing clinical grade recombinant adeno-associated virus using invertebrate cell lines. Hum Gene Ther 28(4):350\u2013360. \n                    https:\/\/doi.org\/10.1089\/hum.2017.042","journal-title":"Hum Gene Ther"},{"key":"18_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2016.2","volume":"3","author":"N Clement","year":"2016","unstructured":"Clement N, Grieger JC (2016) Manufacturing of recombinant adeno-associated viral vectors for clinical trials. Mol Ther Methods Clin Dev 3:16002. \n                    https:\/\/doi.org\/10.1038\/mtm.2016.2","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"18_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nbt1073","volume":"23","author":"Z Wang","year":"2005","unstructured":"Wang Z, Zhu T, Qiao C et al (2005) Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 23(3):321\u2013328","journal-title":"Nat Biotechnol"},{"issue":"22","key":"18_CR22","doi-asserted-by":"publisher","first-page":"7827","DOI":"10.1073\/pnas.0802866105","volume":"105","author":"L Zhong","year":"2008","unstructured":"Zhong L, Li B, Mah CS et al (2008) Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc Natl Acad Sci U S A 105(22):7827\u20137832. \n                    https:\/\/doi.org\/10.1073\/pnas.0802866105","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Methods in Molecular Biology","Viral Vectors for Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9065-8_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T05:06:06Z","timestamp":1558069566000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9065-8_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493990641","9781493990658"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9065-8_18","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"1 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}